The present invention relates to novel bicyclic compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment and prevention of various disorders that are related to α4β2 nicotinic receptors.
本发明涉及公式(I)的新颖
双环化合物及其衍
生物、前药、互变异构体、立体异构体、多晶型、溶剂合物、
水合物、代谢物、N-氧化物、药学上可接受的盐以及含有它们的组合物。本发明还涉及制备上述新型化合物及其衍
生物、前药、互变异构体、立体异构体、多晶型、溶剂合物、
水合物、代谢物、N-氧化物、药学上可接受的盐以及含有它们的组合物的方法。这些化合物对与α4β2
烟碱受体相关的各种疾病的治疗和预防具有用处。